Manion Douglas J. purchased ~$100K in Aclaris Therapeutics, Inc. stock
Aclaris Therapeutics, Inc. (ACRS) · Pres and CEO · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
+22.4%vs SPY +9.3%
Trade Details · Public SEC Filing
Insider
Manion Douglas J.
Role
Pres and CEO
Transaction
Open-Market Purchase
Approx. Value
~$100K
Trade Date
Mar 9, 2023
Company
Aclaris Therapeutics, Inc.
Ticker
ACRSSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$100K purchase
A personal investment by a corporate insider. Even smaller trades can be meaningful when combined with other factors like timing and role.
Pres and CEO
CEOs have the deepest knowledge of company operations. Academic research shows CEO purchases outperform other insider trades by a wide margin.
+22.4% in 90 days (S&P 500: +9.3%)
This trade beat the S&P 500 by 13.1 percentage points over 90 days. We track performance on every insider trade so you can see who consistently outperforms.
How good is Manion Douglas J. at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
On March 9, 2023, Manion Douglas J. — Pres and CEO of Aclaris Therapeutics, Inc. — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$100K in Aclaris Therapeutics, Inc. (ACRS) stock.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, ACRS returned +22.4% versus +9.3% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Manion Douglas J. trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More ACRS Insider Activity
Leonard Braden Michael
Jun 11, 2024
~$4.0M
STRONG
Balthaser Kevin
Mar 2, 2023
~$1.1M
STRONG
Walker Neal
Mar 10, 2022
~$1.5M
STRONG
Walker Neal
Jun 2, 2021
~$2.7M
VS
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free